[与急性髓性白血病无关的骨髓移植是从阳性夜间血红蛋白尿症演变而来的]
Wakana Takahashi1, Nobuaki Fukushima1, Tomoya Arakawa1
1Department of Hematology and Oncology, Konan Kosei Hospital.
概括
阴性夜间血红蛋白尿 (PNH) 可以发展为急性髓性白血病 (AML). 本案例研究详细介绍了在患有PNH病史的患者中,成功的与AML无关的骨髓移植.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 干细胞生物学 干细胞生物学
背景情况:
- 性夜间血红蛋白尿症 (PNH) 是一种罕见的克隆性造血干细胞疾病.
- 患有PNH的患者患有骨髓质疏松综合征 (MDS) 和急性骨髓性白血病 (AML) 的风险增加.
研究的目的:
- 报告急性髓性白血病 (AML) 的病例,在诊断出阳性夜间血红蛋白尿 (PNH) 后13年后发生.
- 在这个病人身上描述全源造血干细胞移植 (HSCT) 的管理和结果.
主要方法:
- 患者接受了诱导化疗,随后进行了与其无关的HSCT,并采用了骨髓衰变调节方案.
- 在移植后,使用了抗补充抑制剂Ravulizumab.
主要成果:
- 患者在HSCT后实现了完全缓解和完整的供体移植.
- 移植是成功的,没有严重的移植与宿主疾病或鼻腔阻塞综合征.
结论:
- 在有PNH病史的患者中,异构HSCT可以成功治疗AML.
- 需要进一步的研究来评估抗补剂抑制剂在HSCT期间的安全性和有效性,用于PNH相关的髓状瘤.
相关概念视频
Bone Marrow Sampling and Transplants
266
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
266
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K


